Alcyone MEMS Cannula (AMC) System
Cannula, Ventricular. 510(k) K150660, from Alcyone Lifesciences, Inc. (Lowell, MA). Product code HCD, class 1.
As of Nov 20, 2026, K150660 is an FDA 510(k) held by Alcyone Lifesciences, Inc., substantially equivalent on Apr 16, 2015 after 34 days, with no recalls tied to it in FDA's recall database.
- Review time: 34 days
- Recalls: 0
The Alcyone MEMS Cannula (AMC) System consisting of the AMC and the AMC Extension Line Set, is intended for injection of Cytarabine (cytosine arabinoside) or removal of cerebrospinal fluid (CSF) from the ventricles of the brain during intracranial procedures. The AMC System is not intended for implant. The device is intended for "single patient use only."
- Surgivision Mr Compatible Ventricular CannulaK102101 · Surgivision, Inc. · Jan 26, 2011
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional, third-party review
- Received
- Mar 13, 2015
- Review panel
- Neurology
- Regulation
- 21 CFR 882.4060
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files